| Top 50 Most Viewed Posts Last Week |
|---|
|
Today This Week Last Week This Month Last Month
|
| 1. Rosner: Short Interest Report As of Sat, Aug 3, '13 (1171) |
2. KenChowder: For what it's worth, Dr. Max Lataillade is not (885)  (23) |
| 3. Plotinus: It would be of interest to see the protocol for (701) (25) |
| 4. ohm20: Cytodyn doesn’t have enough $ resources to (659) (17) |
| 5. cardamine: Just as a positive future indicator amid all this (647) (21) |
| 6. MGK_2: Exactly cardamine. Most of the impurities have (635) (6) |
| 7. Drano: And that is exactly why this Pestell garbage has (635) (5) |
| 8. Evil Rabbit: Someone posted on Stock Twits that Eagle Bay, the (609) (15) |
| 9. Niele: As the share price dips, we are here bickering (604) (26) |
| 10. ohm20: New opinion piece by 3 prominent researchers (602) (26) |
| 11. Respert24: Hard pass for me on that link. I think what (602) (32) |
| 12. ohm20: It's far more likely that the company hired a (573) (21) |
| 13. My69z: Breast Cancer & Cytodyn: Our Dr. Ueno: Dr. Ueno (569) (7) |
| 14. BZE: Sentiment will improve imo after: 1) Results of (563) (13) |
| 15. biloxiblues: A good interview (557) (7) |
| 16. My69z: May 2022 on Pestell: Dr. Pestell and the Company (557) (7) |
| 17. USS JOHNSTON: Bill Ackman - who runs an 18 billion dollar hedge (552) (15) |
| 18. mountaineer: We are sure! Personally I skip over your posts. (545) (13) |
| 19. Evil Rabbit: They burned themselves with the last call by (543) (9) |
| 20. MGK_2: You keep provoking. What do you even stand for? (539) (5) |
| 21. ohm20: fixed your post viewed as too crazy at the (538) (8) |
| 22. Evil Rabbit: You can switch to desktop on your phone. Not a (537) (9) |
| 23. HHIGambler: For those of you who noticed MGK_2's two posts (537) (14) |
| 24. biloxiblues: https://www.reddit.com/r/Livimmune/comments/1gryd (534) (6) |
| 25. Ramjet: I've been hearing and reading the same thing that (534) (2) |
| 26. ohm20: Had a number of options go zero as they expired (531) (21) |
| 27. Respert24: Hold up. Did you say "pharmacy"? They distribute (526) (17) |
| 28. rodolfo: Dropping the share-price ? YES OF COURSE : You (519) (11) |
| 29. Evil Rabbit: Readership is secondary to my primary purpose. (518) (12) |
| 30. KenChowder: My, is this the project from 2022, the product of (516) (3) |
| 31. Evil Rabbit: Everyone here just wants to not think outside the (515) (4) |
| 32. KenChowder: In October 2021, the Company hired Alok Krishen, (515) (18) |
| 33. Respert24: I do think it's smart to get a question or two (511) (31) |
| 34. My69z: and demonstrated that allogeneic immunity was the (511) (5) |
| 35. Evil Rabbit: Are you trying to clutter the board on purpose? (508) (8) |
| 36. Drano: New opinion piece by 3 prominent researchers (504) (8) |
| 37. mountaineer: Today I was able to buy more shares than I had as (497) (13) |
| 38. HHIGambler: Spoken like a true newbie (account created only 8 (496) (17) |
| 39. ohm20: Exactly. Only 3 occurrences will bring about a (488) (25) |
| 40. Buddyboy20: Pretty even points on today's selling. It looks (487) |
| 41. sunray3: Exactly. And Clinton Yam MD is now on the SAB, as (485) (11) |
| 42. HHIGambler: If you knew, or at least understood, all of the (483) (19) |
| 43. Shelly2626: Exactly...but now we are ready for the Boom .. (481) (3) |
| 44. My69z: Project Number 5R01AI129703-08 Former Number (472) (8) |
| 45. Plotinus: Thanks for the link Drano, the editorial is on (471) (19) |
| 46. ohm20: It looks like Leronlimab will compliment (457) (25) |
| 47. Jake2212: " Syneos Health has helped to develop or (457) (24) |
| 48. Ramjet: I agree. Once these trials and studies take (453) (7) |
| 49. BZE: General question on Cytodyn communications: Do (452) |
| 50. BZE: Quote: "The one sticking point is the financials. (449) (7) |
